Ex vivo and In vitro antiplasmodial activities of approved drugs predicted to have antimalarial activities using chemogenomics and drug repositioning approach

High malaria mortality coupled with increased emergence of resistant multi-drug resistant strains of Plasmodium parasite, warrants the development of new and effective antimalarial drugs. However, drug design and discovery are costly and time-consuming with many active antimalarial compounds failing...

Full description

Bibliographic Details
Main Authors: Douglas O. Ochora, Reagan M. Mogire, Rael J. Masai, Redemptah A. Yeda, Edwin W. Mwakio, Joseph G. Amwoma, Dancan M. Wakoli, Abiy Yenesew, Hoseah M. Akala
Format: Article
Language:English
Published: Elsevier 2023-08-01
Series:Heliyon
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2405844023060711